Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Altimmune Inc (NQ: ALT )

7.230 +0.150 (+2.12%)
Streaming Delayed Price Updated: 10:26 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Altimmune Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Gold Drops Over 1%; Existing Home Sales Surge In February
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.65% to 32,455.57 while the NASDAQ rose 0.57% to 11,741.91. The S&P 500,... 
Via Benzinga
META Stock Price Prediction: Can Meta Platforms Really Hit $250?
Meta Platforms (META) stock is worth checking on Tuesday as investors react to a new rating and price target for the shares. 
Via InvestorPlace
Why Is Altimmune (ALT) Stock Down 67% Today?
Altimmune (ALT) stock is losing value on Tuesday after the company released results from a Phase 2 clinical trial for obesity. 
Via InvestorPlace
US Stocks Open Higher; Nasdaq Jumps Over 100 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.90% to 32,535.25 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Analyst Ratings for Altimmune
Via Benzinga
Looking Into Altimmune's Return On Capital Employed
Via Benzinga
Earnings Outlook For Altimmune
Via Benzinga
4 Analysts Have This to Say About Altimmune
Via Benzinga
Altimmune Stock Is Diving: What's Going On?
Shares of clinical-stage biopharmaceutical company Altimmune Inc (NASDAQ: ALT) are trading lower Tuesday after the company announced results from an interim analysis of 
Via Benzinga
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
7 Small-Cap Stocks with Big Growth Potential in 2023
Some of the greatest investment opportunities can be found in these top small-cap stocks to buy in the new year. 
Via InvestorPlace
Altimmune Touts Encouraging Data From Fatty Liver Disease Study
Via Benzinga
Recent Selloff Is A 'Buying Opportunity' For This NASH Stock, Says Analyst
Via Benzinga
Expert Ratings for Altimmune
Analysts have provided the following ratings for Altimmune (NASDAQ:ALT) within the last quarter: 
Via Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical... 
Via Benzinga
Lucid Group, Verona Pharma And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
Via Benzinga
My 3 Top Biotech Stock Picks for 2023
Biotech stocks are set to shine in 2023. 
Via The Motley Fool
What 4 Analyst Ratings Have To Say About Altimmune
Over the past 3 months, 4 analysts have published their opinion on Altimmune (NASDAQ:ALT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A. 
Via Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. 
Via Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
Via Benzinga
Dow, S&P 500 Turn Lower; Altimmune Shares Slide
U.S. stocks pared gains toward the end of trading, with the Dow Jones dropping around 80 points on Wednesday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.